• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WOLVERINE CORONARY CUTTING BALLOON MONORAIL; CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING Back to Search Results
Model Number 3851
Device Problem Device Dislodged or Dislocated (2923)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/17/2019
Event Type  malfunction  
Manufacturer Narrative
Age at time of event: 18 years or older.(b)(6).
 
Event Description
It was reported that a blade lifted.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified left anterior descending artery (lad).After ablation was performed with a 1.5 mm rotablator, a 10 mm x 2.75 mm wolverine coronary cutting balloon monorail was used to dilate the target lesion in combination with a guidezilla ii.The wolverine was inflated to its maximum, 12 atmospheres 5 times.A larger 1.75 mm rotablator was used after checking the intravascular ultrasound (ivus).The lesion was then dilated using the wolverine at a maximum 12 atmospheres for 5 times.The procedure was completed after confirming the dilatation of the lesion area with ivus.After completing the procedure, the wolverine was checked outside the patient body and it was noticed that the bonding on the proximal side of one blade was lifted and was about to break or separate.No patient complications were reported in relation to this event.
 
Manufacturer Narrative
Age at time of event: 18 years or older.Initial reporter facility name: (b)(6).Device evaluated by mfr: the wolverine device was received and analyzed.A section of one of the blades and pads was returned lifted from the balloon material.A visual and microscopic examination was performed on the blades of the returned device.It was noted that approximately 5mm of one of the blades and pads was lifted from the proximal end of the balloon material, the remaining 5mm of blade and pad was intact an undamaged.This damage is consistent with resistance encountered during removal of the device.All other blades were intact and undamaged.No issues were noted with the blades or pads that could have contributed to the damage identified.A visual and tactile examination identified multiple kinks along the hypotube of the device.This type of damage is consistent with excessive force being applied to the delivery system.No issues were noted with the hypotbe that may have contributed to the complaint incident.A visual and microscopic examination was performed on the returned balloon material.The balloon material was returned unfolded which indicates the balloon had been subjected to positive pressure.The returned device was attached to an encore inflation unit and positive pressure was applied.The balloon was successfully inflated to its rate of burst pressure of 12atm (atmospheres) with no issues noted.The inflation device was verified at 12atm (atmospheres), before and after use with a calibrated pressure gauge.No issues were identified with the balloon material that could have contributed to the complaint incident.A visual and microscopic examination identified no damage or any issues with the tip or markerbands of the device.No other issues were identified during the product analysis.
 
Event Description
It was reported that a blade lifted.The 90% stenosed target lesion was located in the moderately tortuous and severely calcified left anterior descending artery (lad).After ablation was performed with a 1.5 mm rotablator, a 10 mm x 2.75 mm wolverine coronary cutting balloon monorail was used to dilate the target lesion in combination with a guidezilla ii.The wolverine was inflated to its maximum, 12 atmospheres 5 times.A larger 1.75 mm rotablator was used after checking the intravascular ultrasound (ivus).The lesion was then dilated using the wolverine at a maximum 12 atmospheres for 5 times.The procedure was completed after confirming the dilatation of the lesion area with ivus.After completing the procedure, the wolverine was checked outside the patient body and it was noticed that the bonding on the proximal side of one blade was lifted and was about to break or separate.No patient complications were reported in relation to this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WOLVERINE CORONARY CUTTING BALLOON MONORAIL
Type of Device
CATHETER, PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA), CUTTING/SCORING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key8317488
MDR Text Key135431425
Report Number2134265-2019-00904
Device Sequence Number1
Product Code NWX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 03/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/04/2020
Device Model Number3851
Device Catalogue Number3851
Device Lot Number0022894347
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/12/2019
Initial Date Manufacturer Received 01/17/2019
Initial Date FDA Received02/07/2019
Supplement Dates Manufacturer Received03/13/2019
Supplement Dates FDA Received03/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GUIDEZILLA II; GUIDEZILLA II; ROTABLATOR; ROTABLATOR; GUIDEZILLA II; ROTABLATOR
-
-